BALTYMAS is a Lithuanian start-up biotechnology company. Founded in 2011 by young scientists on the basis of the Institute of Biotechnology (Vilnius) it combines scientific experience and knowledge with enterprise for generation of novel biotechnology products.
BALTYMAS develops yeast expression systems and employs them for the synthesis of native recombinant proteins. We offer yeast-expressed viral nucleocapsid proteins for use in diagnostics of viral infections and recombinant human cell proteins for fundamental and applied studies or biopharmaceutical purposes.
Currently BALTYMAS produces 29 products of 10 different recombinant proteins.
We are also opened for contract studies of expression of various recombinant proteins in yeasts.
Recombinant protein, protein, recombinant, product, production, nucleocapsid protein, nucleoprotein, viral, virus, human, chaperone, endoplasmic reticulum, ER, viral nucleocapsid proteins, human chaperones, measles, mumps, Respiratory Syncytial Virus, parainfluenza, Human Parainfluenza Virus Type 1, Human Parainfluenza Virus Type 3, influenza, Influenza A virus, Influenza B virus, ERp57, human ERp57, PDIA3, GRP78/BiP, human GRP78, human BiP, Calreticulin, human calreticulin, active, native, native recombinant, Pichia pastoris, Saccharomyces cerevisiae, yeast, CRT, CALR, wild-type, strain, vaccine, diagnostic, diagnostics, reagent, laboratory, biological, activity, frozen, lyophilized, lyophilization, glycerol stock, nucleocapsid-like particles, NLPs, purified, native conditions, analogues, application, superior, bulk, amount, quantity, selling, supplier, contract, research, order, contact, request, Description, major, antigenic, determinant, infection, disease, full-length, expressed, ultracentrifugation, analytical methods, electron microscopy, EM, herring-bone morphology, optimized, extremely, stable, reproducibility, Lot, Storage, partial degradation, stability, post-translational, modification, phosphorylation, N-terminal, processing, improved, reactivity, immunoassays, oligomerization, important, development, assay, formulation, purity, highly pure, special, functional, therapeutic, pharmaceuticals, tag-free, correctly processed, oligomer, ATPase, Escherichia coli, bacteria, advantages, multifunctional, Catalogue, service, Publications, identical, titer, positive, human sera, serum, ELISA, rapid, immunochromatographic, preferable, quality, batch, preparation, negative staining, uranyl, magnification, Form:, Storage:, shipment, shipped, cost, Concentration, SDS-PAGE, Western blot, References, Size, Cat. No., Price, Inquiry, reconstitution, synthesis, point-of-care, test, diagnosis, detection, serology, IgM, IgG, antibodies, antigen, outbreak, oral fluid, kDa, GenBank, non-denaturing, serotype, H3N2, highly reactive, Ultrapure, ESI-MS, acetylated, vial, PBS, B/Singapore/222/79, B/Lee/1940, chromatographic techniques, isoforms, minor, intact, amino acid sequence, mature protein, signal peptide, secreted, thiol-dependent reductase, disulfide isomerase, precursor, monomeric, soluble, discount, expression system, intracellular, purification, humanized, commercial, specific, secretion pathway, suitable, optimal, eukaryotic, polypeptide, heterologous, contaminations, tools, biopharmaceuticals, properties, less expensive, market, purchase, customer, company, unique, patent, submit, novel, fundamental, applied, biotechnology, Lithuania, Lithuanian, Vilnius.